NCT06884397 Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery
| NCT ID | NCT06884397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier de la Rochelle Ré Aunis |
| Condition | Abdominal Aortic Aneurysms (AAA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-04-14 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-04-14 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Abdominal aortic aneurysm, a condition characterised by an increase in the diameter of the aorta, can be treated either surgically or endovascularly. In the latter, an endoprosthesis consisting of a metal spring covered with an impermeable fabric is inserted through an artery and deployed inside the aorta. This new method appears to be less invasive than surgery, but its long-term results are not yet fully understood. As a result, patients who have undergone this treatment are monitored by their surgeon to ensure that there is no endoleak. Several research teams have proposed analysing medical images to predict this risk of endoleak. Doctors are now trying to use artificial intelligence to automate the analysis of these images.
Eligibility Criteria
Inclusion Criteria: * Treated for an abdominal aortic aneurysm through endovascular prosthesis implantation Exclusion Criteria: * Underwent intraoperative embolization of the inferior mesenteric artery or aneurysmal sac * Refuse the use of their data
Contact & Investigator
Sébastien Franco, MD
STUDY DIRECTOR
Groupe Hospitalier de la Rochelle Ré Aunis
Frequently Asked Questions
Who can join the NCT06884397 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Abdominal Aortic Aneurysms (AAA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06884397 currently recruiting?
Yes, NCT06884397 is actively recruiting participants. Contact the research team at caroline.allix-beguec@ght-atlantique17.fr for enrollment information.
Where is the NCT06884397 trial being conducted?
This trial is being conducted at La Rochelle, France.
Who is sponsoring the NCT06884397 clinical trial?
NCT06884397 is sponsored by Groupe Hospitalier de la Rochelle Ré Aunis. The principal investigator is Sébastien Franco, MD at Groupe Hospitalier de la Rochelle Ré Aunis. The trial plans to enroll 300 participants.